ANI制药 ANIP 深 沪
等待开盘 11-08 09:30:00 美东时间
91.49
+1.260
+1.40%
华盛通- 最 高95.22
- 今 开85.78
- 成交量 37.62万股
- 最 低 79.39
- 昨 收 90.23
- 总市值 20.39亿
- 52周最高 99.50
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 52.50
- 委 比 63.64%
- 总股本 2229.17万
- 历史最高 99.50
- 量 比 2.19
- 振 幅 17.54%
- 历史最低 0.80
- 每 手 1
- 风险率 14.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ANI Pharmaceuticals Q3 Adj. EPS $2.04 Beats $1.75 Estimate, Sales $227.813M Beat $211.041M Estimate
ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.75 by 16.31 percent. This is a 52.24 percent increase over earnings of $1.34 per share from
11-07 19:51
Earnings Scheduled For November 7, 2025
Companies Reporting Before The Bell • Kiora Pharmaceuticals (NASDAQ:KPRX) is pr...
11-07 19:11
What's Next: Liquidia's Earnings Preview
Liquidia (NASDAQ:LQDA) is set to give its latest quarterly earnings report on M...
11-01 00:03
ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting
ANI Pharmaceuticals announced that results from the NEW DAY clinical trial of ILUVIEN for diabetic macular edema (DME) will be presented in a late-breaking oral presentation at the American Academy of Ophthalmology (AAO) 2025 Meeting. The presentation, titled "A Randomized, Active-Controlled Trial of Fluocinolone Acetonide 0.19mg Intravitreal Implant for Diabetic Macular Edema: The NEW DAY Study," will be delivered by Victor H. Gonzalez, MD, duri...
10-16 10:50
美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
Truist Securities Maintains Hold on ANI Pharmaceuticals, Raises Price Target to $90
Truist Securities analyst Gregory Fraser maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Hold and raises the price target from $77 to $90.
10-09 22:41
Adani Ports Receives SEBI Compliance Certificate for Q3 2025
An announcement from Adani Ports & Special Economic Zone Ltd ( ($IN:ADANIPO...
10-07 02:35
ANI Pharmaceuticals Completes Mandatory Conversion of Preferred Shares
The latest announcement is out from ANI Pharmaceuticals ( ($ANIP) ). On Novembe...
09-27 05:30
美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
09-25 09:52
